Attached files
Exhibit 32.1
CERTIFICATION
OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT
TO 18 U.S. C. SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the annual report on Form 10-K of Aytu BioScience,
Inc. (the “Company”) for the fiscal year ended June 30,
2020, as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), each of Joshua R. Disbrow,
Chief Executive Officer (Principal Executive Officer), and David A.
Green, Chief Financial Officer (Principal Financial Officer and
Principal Accounting Officer), of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to his knowledge:
(1)
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
(2)
The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
|
|
|
|
|
Date:
October
6, 2020
|
|
|
/s/ Joshua R.
Disbrow
|
|
|
|
|
Joshua
R. Disbrow
|
|
|
|
|
Chief
Executive Officer (Principal Executive Officer)
|
|
|
|
|
|
|
Date:
October
6, 2020
|
|
|
/s/ David A.
Green
|
|
|
|
|
David
A. Green
|
|
|
|
|
Chief
Financial Officer (Principal Financial Officer and Principal
Accounting Officer)
|